Clinical Trial

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Name: Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma — clinical trial record (NCT05008965)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2021-08-16; most recent amendment 2026-01-09.

Trial Details

NCT Number	NCT05008965
Lead Sponsor	Oneness Biotech Co., Ltd. Collaborators: Microbio Shanghai Co., Ltd.
Conditions	Allergic Asthma
Enrollment	100 participants
Start Date	2021-07-27
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-12